9.23 AM: Cadila Healthcare share price rose over 7 percent on August 23

Cadila

Cadila Healthcare share price rose over 7 percent on August 23 after company received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D.

” . has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world’s first Plasmid DNA Vaccine for COVID-19,” company said in the release.

ZyCoV-D is a three dose vaccine which will be administered first on day zero, day 28th and then on the 56th day.

News Source:- Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from bigprofitbuzz.com.

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button